Verona Pharma plc·4

Nov 3, 7:53 PM ET

Deschamps Lisa 4

4 · Verona Pharma plc · Filed Nov 3, 2021

Insider Transaction Report

Form 4
Period: 2021-11-02
Transactions
  • Sale

    Ordinary Shares

    2021-11-02$0.66/sh11,672$7,69081,984 total
Footnotes (4)
  • [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
  • [F2]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units.
  • [F3]The price reported represents the sale price of the Issuer's ADSs divided by eight (8).
  • [F4]Consists of (i) 29,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 3,625 ADSs); and (ii) 52,984 Ordinary Shares underlying 6,623 ADSs.

Documents

1 file
  • 4
    tm2131837-5_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT